about
Natural selection of tumor variants in the generation of "tumor escape" phenotypesCyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptorsChronic immune activation and inflammation as the cause of malignancyLung cancer. 1: prevention of lung cancerGene Therapy Applications to Cancer TreatmentRegular aspirin use and lung cancer risk.Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study.Myeloid suppressor cells and immune modulation in lung cancerLung cancer: a classic example of tumor escape and progression while providing opportunities for immunological interventionInhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21Aspirin and lung cancer in womenInduction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanateReduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control studyIndomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expressionAlterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinomaNon-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44p27 suppresses cyclooxygenase-2 expression by inhibiting p38β and p38δ-mediated CREB phosphorylation upon arsenite exposureCeramide 1-phosphate is required for the translocation of group IVA cytosolic phospholipase A2 and prostaglandin synthesis.Growth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells.Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells.Biological activity of celecoxib in the bronchial epithelium of current and former smokers.Restoration of leukotriene B(4)-12-hydroxydehydrogenase/15- oxo-prostaglandin 13-reductase (LTBDH/PGR) expression inhibits lung cancer growth in vitro and in vivo.Smoking and lung cancer: the role of inflammation.Microvessel density is a prognostic marker of human gastric cancer.Cyclooxygenase-2 inhibitors for non-small-cell lung cancer: A phase II trial and literature review.Targeting the eicosanoid pathway in non-small-cell lung cancer.Recombinant viral capsid protein VP1 suppresses lung cancer metastasis by inhibiting COX-2/PGE2 and MIG-7.Redox Factor-1 Inhibits Cyclooxygenase-2 Expression via Inhibiting of p38 MAPK in the A549 Cells.Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.Regulation of COX-2 expression by miR-146a in lung cancer cellsThe EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese.Dioscorea japonica extract down-regulates prostaglandin E2 synthetic pathway and induces apoptosis in lung cancer cells.COX-2 expression in papillary thyroid carcinoma (PTC) in cytological material obtained by fine needle aspiration biopsy (FNAB).Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent mice.Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer.Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasionHonokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signalingThe association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapy
P2860
Q24551158-23D863AE-37E7-4B83-88F5-87786AC55991Q24648434-7C710C64-17E6-4447-8F2D-A0715EC97F46Q24648532-6D943687-7996-43DD-815D-DB49322BF0B9Q24678926-A9CDB12E-8707-4403-B578-9DC3001C0AEDQ24792808-6F9EBB7F-E489-4E66-98BF-9662903A44A4Q24803838-53458BED-4031-4731-B617-F2034E35670BQ25257445-595FC463-4FDF-486D-BDBE-D4B4113063E3Q26823251-01196FB8-B0B7-48AF-985F-D9210A06DA1DQ26850218-351646F2-1707-4F6D-8255-249DABD3082BQ28192797-83B5A6CA-9F7C-479A-848D-C754B951A1EEQ28193281-6F292AB9-10A4-4494-8E98-98CEEB28A294Q28211715-BAD3C1E4-B393-4054-B2E3-458EA0DF30BAQ28217572-29E29D91-8602-4396-9B52-10B6A7913990Q28344807-6AB6C555-053F-4BE2-AA11-8B443B03A66AQ28360358-FA0CA3D8-0AAF-4D5B-990E-76BC0B63DEBDQ28363575-546E3647-78C6-423F-B31D-CBAA43CA9CA1Q28384606-4E26FF18-6F50-45AD-8BC8-72D295BF2751Q30492050-DAF43C0C-9B07-4A6B-9506-76C038CE6D94Q33183406-05796791-B4A3-4C54-A722-5083922179DDQ33356757-CA101F53-EF48-47F1-A9CF-06ED11C536DAQ33640402-42170033-51CF-4FF7-A37B-1B603AFF19A8Q33759512-F201243B-03EA-433E-BDF1-AAF7AB0CF2A0Q33842487-0497F543-2D6B-496F-8FFE-1214448CC01AQ33868722-2FBB11F8-DCD4-49BD-A0B4-497AE31572B0Q33932736-F008F791-5077-4B7E-A6D5-56FC569BB559Q33936807-01A5078B-A4DF-4500-88C9-B55904296831Q33977140-129E3905-C2D1-4877-93D9-82F3CC885FFBQ33988344-080AF474-C767-46B5-99A1-9614832C1022Q34008146-8C187648-5807-4213-A4B5-99AB015FDA82Q34067248-A880F8D0-6FE3-4AA2-ABC2-A44BC9CC80C7Q34194320-5E8F75A6-CD98-418D-8255-3E39B69BA799Q34302223-E301FF1E-5214-44A8-BD1B-A2D6E7E9759FQ34326547-B7B75780-E5D1-49FF-BFD7-4D4D2DD020F2Q34489929-ECB191E0-4F9D-4640-A6E6-FE3F53CC85FDQ34516134-F519DF4A-A88A-4BE4-8324-F3D6CDFD8348Q34516556-608EA1DD-0E7F-4DBE-8CC8-317A5B720780Q34521937-8BBFCB80-C209-47A4-BF8B-4C282418E296Q34646962-ADF90678-261F-46C4-B908-B68ED210752DQ34666257-DD57A2DF-D4CB-4C94-9D1C-57D5626BAD1BQ34689044-12142E64-E4E7-464F-AE79-00E790F82D40
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Expression of cyclooxygenase-2 in human lung carcinoma.
@ast
Expression of cyclooxygenase-2 in human lung carcinoma.
@en
Expression of cyclooxygenase-2 in human lung carcinoma.
@nl
type
label
Expression of cyclooxygenase-2 in human lung carcinoma.
@ast
Expression of cyclooxygenase-2 in human lung carcinoma.
@en
Expression of cyclooxygenase-2 in human lung carcinoma.
@nl
prefLabel
Expression of cyclooxygenase-2 in human lung carcinoma.
@ast
Expression of cyclooxygenase-2 in human lung carcinoma.
@en
Expression of cyclooxygenase-2 in human lung carcinoma.
@nl
P2093
P1433
P1476
Expression of cyclooxygenase-2 in human lung carcinoma.
@en
P2093
Karjalainen A
Ristimäki A
Saukkonen K
P304
P407
P577
1998-11-01T00:00:00Z